Get started
Author

Pierre Corbeau

Observed names: CORBEAU, Pierre, Corbeau Pierre, Corbeau, P., Corbeau, Pierre, P CORBEAU, P Corbeau, P. Corbeau, PIERRE CORBEAU
Observed institutions: Centre National de la Recherche Scientifique, National Institutes of Health, Inserm, Université de Montpellier, University of California San Diego, Centre Hospitalier Universitaire de Montpellier, Centre Hospitalier Universitaire de Nîmes, Hôpital Gui de Chauliac, Centre de Recherche en Biologie cellulaire de Montpellier, Hôpital Lapeyronie, National Institute of Allergy and Infectious Diseases, Hôpital Saint Eloi, Institut Pasteur de Nouvelle Calédonie, Institut de Génomique Fonctionnelle, Institut de Génétique Humaine, Université Montpellier 1
ORCID: 0000-0002-8576-6683
Observed ORCID: 0000-0002-8576-6683
OpenAlex ID: A5040930956
Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication
2007 · Robinson Triboulet, Bernard Mari, et al. · Science · 628
Suv39H1 and HP1γ are responsible for chromatin‐mediated HIV‐1 transcriptional silencing and post‐integration latency
2007 · Isaure du Chéné, Euguenia Basyuk, et al. · The EMBO Journal · 312
PDF
Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection
2011 · Pierre Corbeau, Jacques Reynes · Blood · 206
CD4+T Cell Surface CCR5 Density as a Determining Factor of Virus Load in Persons Infected with Human Immunodeficiency Virus Type 1
2000 · Jacques Reynes, Pierre Portales, et al. · The Journal of Infectious Diseases · 178
PDF
T cell apoptosis characterizes severe Covid-19 disease
2022 · Sonia André, Morgane Picard, et al. · Cell Death and Differentiation · 176
PDF
Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study
2007 · A. Jeandrot, J.-L. Richard, et al. · Diabetologia · 160
PDF
Immune activation in the course of HIV ‐1 infection: Causes, phenotypes and persistence under therapy
2015 · M Younas, C Psomas, et al. · HIV Medicine · 159
Development of HIV vectors for anti-HIV gene therapy.
1996 · E Poeschla, P Corbeau, et al. · Proceedings of the National Academy of Sciences · 137
Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection
2002 · Yea-Lih Lin, Clément Mettling, et al. · Proceedings of the National Academy of Sciences · 117
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
2020 · Michelle Rosenzwajg, Randa Salet, et al. · Diabetologia · 107
PDF
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression
2001 · Jacques Reynes, Pierre Portales, et al. · AIDS · 96
Small-Molecule Inhibition of HIV pre-mRNA Splicing as a Novel Antiretroviral Therapy to Overcome Drug Resistance
2007 · Nadia Bakkour, Yea-Lih Lin, et al. · PLoS Pathogens · 93
PDF
Two‐drug vs . three‐drug combinations for HIV ‐1: Do we have enough data to make the switch?
2019 · S Moreno, CF Perno, et al. · HIV Medicine · 83
PDF
An antibody that binds the immunoglobulin CDR3‐like region of the CD4 molecule inhibits provirus transcription in HIV‐infected T cells.
1993 · M. Benkirane, P. Corbeau, et al. · The EMBO Journal · 69
Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line
1996 · Pierre Corbeau, Günter Kraus, et al. · Proceedings of the National Academy of Sciences · 66
Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120
1993 · Jean Favero, Pierre Corbeau, et al. · European Journal of Immunology · 65
Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry
1993 · P Corbeau, M Benkirane, et al. · The Journal of Immunology · 61
Interferon-α restores HIV-induced alteration of natural killer cell perforin expression in vivo
2003 · Pierre Portales, Jacques Reynes, et al. · AIDS · 60
Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system
1998 · P Corbeau, G Kraus, et al. · Gene Therapy · 54
The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment
2005 · B. Guillot, P. Portales, et al. · British Journal of Dermatology · 48
Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations
2004 · Carole Crozet, Yea-Lih Lin, et al. · Journal of Cell Science · 47
PDF
Mesenchymal Stem Cell-Dependent Formation of Heterotopic Tendon-Bone Insertions (Osteotendinous Junctions)
2010 · Sandra Shahab-Osterloh, Frank Witte, et al. · Stem Cells · 45
Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease
1991 · P. Poncelet, G. Poinas, et al. · Research in Immunology · 45
Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia
2019 · Mehwish Younas, Christina Psomas, et al. · Frontiers in Immunology · 44
PDF
Maraviroc Intensification of Stable Antiviral Therapy in HIV-1–Infected Patients With Poor Immune Restoration
2012 · Lise Cuzin, Selma Trabelsi, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 44
Works count: 151
Citation count: 4,415
H-index: 34
I10-index: 73
Year
Topic
Type